Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Paul W. Heron"'
Publikováno v:
Journal of Medicinal Chemistry. 61:10558-10572
The glycolytic enzyme aldolase is an emerging drug target in diseases such as cancer and protozoan infections which are dependent on a hyperglycolytic phenotype to synthesize adenosine 5'-triphosphate and metabolic precursors for biomass production.
Autor:
Paul W. Heron, Jurgen Sygusch
Publikováno v:
Journal of Biological Chemistry. 292:19849-19860
Fructose-1,6-bisphosphate (FBP) aldolase, a glycolytic enzyme, catalyzes the reversible and stereospecific aldol addition of dihydroxyacetone phosphate (DHAP) and d-glyceraldehyde 3-phosphate (d-G3P) by an unresolved mechanism. To afford insight into
Autor:
Agnieszka Gizak, Janusz Wiśniewski, Paul W. Heron, Dariusz Rakus, Jurgen Sygusch, Piotr Mamczur
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 10, Iss 10, Pp 1-16 (2019)
Cell Death and Disease, Vol 10, Iss 10, Pp 1-16 (2019)
Muscle fructose-1,6-bisphosphate aldolase (ALDOA) is among the most abundant glycolytic enzymes in all cancer cells. Here, we show that the enzyme plays a previously unknown and critical role in a cancer cell survival. Simultaneous inhibition of ALDO
Autor:
Paul Pillot, Anne-Laure Chambon, Joelle Pelé, Clotilde LowKam, Jocelyne Falletto, Jurgen Sygusch, Morgane Leroux, Françoise Beylich, Vincent Barbier, Dominique Kajetanek, Celia Kremer, Magali Legris, Paul W. Heron
Publikováno v:
Acta Crystallographica Section A Foundations and Advances. 70:C1037-C1037
If crystallography is well known to many scientists, this is not true for the general public. Aims of the international year of crystallography include the desire to increase public awareness, to stimulate the intellectual curiosity of students and t